Patents by Inventor Kathryn W. Underwood

Kathryn W. Underwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for identifying agents that interact with MAP kinase activated protein kinase 2
    Patent number: 7167802
    Abstract: This invention is directed to the crystal structures of MK2, and to the use of these structures in rational drug design methods to identify agents that may interact with active sites of MK2 proteins. Such agents may be useful as therapeutic agents.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: January 23, 2007
    Assignee: Wyeth
    Inventors: Kevin D. Parris, Kathryn W. Underwood, Mark L. Stahl, Lidia Mosyak, Kristine Svenson, Tania Shane, Meggin L. Taylor
  • Crystal structure of yqeJ and uses thereof
    Patent number: 7155346
    Abstract: This invention is directed to the crystal structure of yqeJ, and to the use of this structure in rational drug design methods to identify agents that may interact with active sites of yqeJ. Such agents may be useful as antibacterial agents.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: December 26, 2006
    Assignees: Wyeth, Millennium Pharmaceuticals, Inc.
    Inventors: Andrea M. Olland, Mark L. Stahl, Francis X. Sullivan, Kathryn W. Underwood, Rajiv Chopra
  • Crystal structures of MK2 and uses thereof
    Publication number: 20040091872
    Abstract: This invention is directed to the crystal structures of MK2, and to the use of these structures in rational drug design methods to identify agents that may interact with active sites of MK2 proteins. Such agents may be useful as therapeutic agents.
    Type: Application
    Filed: November 13, 2002
    Publication date: May 13, 2004
    Inventors: Kevin D. Parris, Kathryn W. Underwood, Mark L. Stahl, Lidia Mosyak, Kristine Svenson, Tania Shane, Meggin L. Taylor
  • Crystal structure of yqeJ and uses thereof
    Publication number: 20030124699
    Abstract: This invention is directed to the crystal structure of yqeJ, and to the use of this structure in rational drug design methods to identify agents that may interact with active sites of yqeJ. Such agents may be useful as antibacterial agents.
    Type: Application
    Filed: July 31, 2002
    Publication date: July 3, 2003
    Inventors: Andrea M. Olland, Mark L. Stahl, Francis X. Sullivan, Kathryn W. Underwood, Rajiv Chopra